REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 17th, 2018 • Apricus Biosciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 17th, 2018 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of October 16, 2018, by and among Apricus Biosciences, Inc., a Nevada corporation, with headquarters located at 11975 El Camino Real, Suite 300, San Diego, California 92130 (the "Company"), and the investors listed on the Schedule of Buyers attached hereto (each, a "Buyer" and collectively, the "Buyers").
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 17th, 2018 • Apricus Biosciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 17th, 2018 Company Industry JurisdictionSECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of October 16, 2018, by and among Seelos Therapeutics, Inc., a Delaware corporation, with headquarters located at 209 Lukes Wood Road, New Canaan, CT 06840 ("Seelos"), Apricus Biosciences, Inc., a Nevada corporation, with headquarters located at 11975 El Camino Real, Suite 300, San Diego, CA 92130 ("Apricus"), and the investors listed on the Schedule of Buyers attached hereto (individually, a "Buyer" and collectively, the "Buyers").
SEELOS THERAPEUTICS, INC.Lock-Up Agreement • October 17th, 2018 • Apricus Biosciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 17th, 2018 Company Industry Jurisdiction
Amendment No. 1 Agreement and Plan of Merger and ReorganizationAgreement and Plan of Merger and Reorganization • October 17th, 2018 • Apricus Biosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 17th, 2018 Company Industry JurisdictionThis Amendment No. 1 to Agreement and Plan of Merger and reorganization (this “Amendment”), is made and entered into as of October 16, 2018, by and among Apricus Biosciences, Inc., a Nevada corporation (“Apricus”), Arch Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Apricus (“Merger Sub”), and Seelos Therapeutics, Inc., a Delaware corporation (the “Company”). Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in that certain Agreement and Plan of Merger and Reorganization, made and entered as of July 30, 2018, by and among Apricus, Merger Sub and the Company (the “Merger Agreement”).